Leif Schröder is a Research Group Leader of the Molecular Imaging Group at the Leibnitz Institute for Molecular Pharmacology in Berlin. Previously, he spent four years at the University of California at Berkeley, partly supported by an Emmy Noether Fellowship from the German Research Foundation, where he worked on new magnetic resonance imaging techniques based on hyperpolarized xenon biosensors. In 2009, he returned to Germany to join the Leibnitz Institute where he led the Starting Grant Project BiosensorImaging funded by the European Research Council until 2015. His research is dedicated to Nuclear Magnetic Resonance (NMR) spectroscopy and imaging where he currently takes a special interest in hyperpolarised biosensors for NMR and Magnetic Resonance Imaging (MRI).
Share
